TW202237137A - 含戊酸倍他米松（ｂｅｔａｍｅｔｈａｓｏｎｅ ｖａｌｅｒａｔｅ）之軟膏劑組成物 - Google Patents

含戊酸倍他米松（ｂｅｔａｍｅｔｈａｓｏｎｅ ｖａｌｅｒａｔｅ）之軟膏劑組成物 Download PDF

Info

Publication number
TW202237137A
TW202237137A TW111103410A TW111103410A TW202237137A TW 202237137 A TW202237137 A TW 202237137A TW 111103410 A TW111103410 A TW 111103410A TW 111103410 A TW111103410 A TW 111103410A TW 202237137 A TW202237137 A TW 202237137A
Authority
TW
Taiwan
Prior art keywords
ointment
ointment composition
betamethasone valerate
mass
crotamiton
Prior art date
Application number
TW111103410A
Other languages
English (en)
Chinese (zh)
Inventor
村里博志
友田宜孝
岩田洋一
純浦文枝
Original Assignee
日商塩野義醫藥保健股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商塩野義醫藥保健股份有限公司 filed Critical 日商塩野義醫藥保健股份有限公司
Publication of TW202237137A publication Critical patent/TW202237137A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW111103410A 2021-01-26 2022-01-26 含戊酸倍他米松（ｂｅｔａｍｅｔｈａｓｏｎｅ ｖａｌｅｒａｔｅ）之軟膏劑組成物 TW202237137A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021-010487 2021-01-26
JP2021010487 2021-01-26

Publications (1)

Publication Number Publication Date
TW202237137A true TW202237137A (zh) 2022-10-01

Family

ID=82653582

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111103410A TW202237137A (zh) 2021-01-26 2022-01-26 含戊酸倍他米松（ｂｅｔａｍｅｔｈａｓｏｎｅ ｖａｌｅｒａｔｅ）之軟膏劑組成物

Country Status (3)

Country Link
JP (1) JPWO2022163686A1 (https=)
TW (1) TW202237137A (https=)
WO (1) WO2022163686A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
US4083974A (en) * 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
JP4686144B2 (ja) * 2004-07-20 2011-05-18 岩城製薬株式会社 油脂性軟膏剤
JP5965187B2 (ja) * 2012-03-30 2016-08-03 小林製薬株式会社 油性軟膏剤
JP2014111590A (ja) * 2012-11-09 2014-06-19 Taisho Pharmaceutical Co Ltd 軟膏剤

Also Published As

Publication number Publication date
WO2022163686A1 (ja) 2022-08-04
JPWO2022163686A1 (https=) 2022-08-04

Similar Documents

Publication Publication Date Title
KR100802366B1 (ko) 풀베스트란트 제제
US20190060288A1 (en) Topical compoisition comprising tacrolimus
JP2021518409A (ja) 局所用組成物
CN101217963A (zh) 疏水性药物给药系统及含有疏水性药物的组合物
TW202237137A (zh) 含戊酸倍他米松（ｂｅｔａｍｅｔｈａｓｏｎｅ ｖａｌｅｒａｔｅ）之軟膏劑組成物
US20250161323A1 (en) Formulation of long-acting levonorgestrel butanoate injectable depot suspension
JP2023044680A (ja) ベタメタゾン吉草酸エステル及びジフェンヒドラミン含有医薬組成物
JP6975244B2 (ja) 局所用組成物
JPS6218526B2 (https=)
JP5503939B2 (ja) アゼラスチン塩酸塩含有カプセル剤
JP2023044681A (ja) ベタメタゾン吉草酸エステル含有軟膏剤
CA3032912A1 (en) High-concentration fulvestrant compositions
JP2010526783A (ja) 水性医薬組成物
JP3748912B2 (ja) オーレオバシジン類の高濃度溶液製剤
ES2964513T3 (es) Fórmula farmacéutica tópica
JP4169956B2 (ja) 安定化された抗炎症軟膏剤
TW202200155A (zh) 含戊酸倍他米松(betamethasone valerate)之組成物
JP2025095431A (ja) 外用組成物
JPH1059862A (ja) シクロスポリン製剤
JP2026500440A (ja) 優れた薬物動態特性を有するフルベストラントの医薬組成物及びその製造方法
CA3174475A1 (en) Topical pharmaceutical formulations of a cyclic depsipeptide
JPS597682B2 (ja) 軟膏基剤
WO2013115201A1 (ja) 非水性液体組成物
KR20170137117A (ko) 피부용의 의약 조성물
PL214858B1 (pl) Środek leczniczy na bazie noretysteronu lub jego farmaceutycznie dopuszczalnej pochodnej i estradiolu lub jego farmaceutycznie dopuszczalnej pochodnej